What Happened?
Shares of healthcare services provider AdaptHealth Corp. (NASDAQ: AHCO) fell 39.5% in the morning session after the company reported disappointing second-quarter results and significantly cut its full-year financial guidance.
The home medical equipment provider posted a loss of $0.99 per share, a stark contrast to analyst estimates for a $0.15 gain. Revenue for the quarter was $740.3 million, falling short of the expected $847.2 million. Looking ahead, AdaptHealth slashed its 2026 revenue guidance to a new midpoint of $2.87 billion, a significant reduction from its previous forecast of $3.49 billion and well below Wall Street's expectations. The company also cut its adjusted EBITDA outlook to a range of $490 million to $520 million. The company attributed the lowered outlook to challenges with a West Coast partnership and an unexpected price increase from a manufacturer.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy AdaptHealth? Access our full analysis report here, it’s free.
What Is The Market Telling Us
AdaptHealth’s shares are somewhat volatile and have had 13 moves greater than 5% over the last year. But moves this big are rare even for AdaptHealth and indicate this news significantly impacted the market’s perception of the business.
The biggest move we wrote about over the last year was 5 months ago when the stock dropped 16.4% on the news that its fourth-quarter 2025 report revealed a significant loss that overshadowed a revenue beat. While total revenue of $846.3 million surpassed analyst expectations, investors focused on substantial profitability challenges. The company posted a GAAP loss of $0.76 per share, which starkly missed Wall Street's consensus estimate for a $0.35 profit and reversed the $0.37 profit per share reported in the same quarter of the previous year. Highlighting the pressure on profits, the operating margin contracted to negative 8.7% from a positive 11.4% a year ago. Additionally, adjusted EBITDA, a measure of operational profitability, came in at $163.1 million, missing analyst forecasts by over 14%.
AdaptHealth is down 32.4% since the beginning of the year, and at $6.54 per share, it is trading 51.2% below its 52-week high of $13.38 from April 2026. Investors who bought $1,000 worth of AdaptHealth’s shares 5 years ago would now be looking at only $301.01.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
